Fundraising Fox

Persephone Biosciences

YC W18 ↗

San Diego, US · Founded 2017 · Delaware corporation · 6 employees · 8 known investors

persephonebiosciences.com ↗

Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria. The product targets parents seeking to support their babies' digestive health, immune development, and overall microbiome health.

BiotechFemTechHealthtechAI-powered Drug DiscoveryCOVID-19in /18624497/admin/@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (W18)

SCStephanie Culler
Stephanie CullerinFounder/CEO
SVStephen Van Dien
Stephen Van DieninFounder/CTO

Investors · 8

BioBritLa Jolla
Fifty YearsSan Francisco · $250K – $2M
First Bight VenturesHouston · $1M – $2M
Hemi Ventures, LlcPalo Alto · $250K – $500Kvia Amy Gu · inferred
Ocampo CapitalSan Francisco · $1M – $10Mvia Karl Bracken · inferred
Y CombinatorSan Francisco · $500K
DCVC (Data Collective)reportedPalo Alto · $5M – $25M
Susa VenturesreportedSan Francisco · $1M – $5M

Reported raises · per SEC filings

Form D private placements
▶$317KraisedMar 2021 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen Van DienExecutive Officer, Director
  • Stephanie CullerExecutive Officer, Director
Offering amount
$317K
Amount sold
$317K
Minimum investment
$10K
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news